/PRNewswire/ NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,.
/PRNewswire/ NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,.
NuVasive Inc. has announced FDA 510(k) clearance for expanded indication of Attrax putty for use in interbody fusion of the thoracolumbar spine, according to a press release.Attrax putty is a synthetic, biologic and osteoconductive bone void filler, which is designed to perform similar to autograft bone, according to the release.